Merola, J. F., Behrens, F., Magrey, M., Chen, L., Haaland, D., Kato, K., . . . Lippe, R. (2021). Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study. BMJ Publishing Group.
Style de citation Chicago (17e éd.)Merola, Joseph F., et al. Upadacitinib in Patients with Psoriatic Arthritis and an Inadequate Response to Non-biological Therapy: 56-week Data from the Phase 3 SELECT-PsA 1 Study. BMJ Publishing Group, 2021.
Style de citation MLA (8e éd.)Merola, Joseph F., et al. Upadacitinib in Patients with Psoriatic Arthritis and an Inadequate Response to Non-biological Therapy: 56-week Data from the Phase 3 SELECT-PsA 1 Study. BMJ Publishing Group, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.